Details

Autor(en) / Beteiligte

• Alcaide, F.
• Amlerová, J.
• Bou, G.
• Ceyssens, P.J.
• Coll, P.
• Corcoran, D.
• Fangous, M.-S.
• González-Álvarez, I.
• Gorton, R.
• Greub, G.
• Hery-Arnaud, G.
• Hrábak, J.
• Ingebretsen, A.
• Lucey, B.
• Marekoviċ, I.
• Mediavilla-Gradolph, C.
• Monté, M.R.
• O'Connor, J.
• O'Mahony, J.
• Opota, O.
• O'Reilly, B.
• Orth-Höller, D.
• Oviaño, M.
• Palacios, J.J.
• Palop, B.
• Pranada, A.B.
• Quiroga, L.
• Rodríguez-Temporal, D.
• Ruiz-Serrano, M.J.
• Tudó, G.
• Van den Bossche, A.
• van Ingen, J.
• Rodriguez-Sanchez, B.

Titel

How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry

Ist Teil von

• Clinical microbiology and infection, 2018-06, Vol.24 (6), p.599-603

Ort / Verlag

England: Elsevier Ltd

Erscheinungsjahr

2018

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• The implementation of MALDI-TOF MS for microorganism identification has changed the routine of the microbiology laboratories as we knew it. Most microorganisms can now be reliably identified within minutes using this inexpensive, user-friendly methodology. However, its application in the identification of mycobacteria isolates has been hampered by the structure of their cell wall. Improvements in the sample processing method and in the available database have proved key factors for the rapid and reliable identification of non-tuberculous mycobacteria isolates using MALDI-TOF MS. The main objective is to provide information about the proceedings for the identification of non-tuberculous isolates using MALDI-TOF MS and to review different sample processing methods, available databases, and the interpretation of the results. Results from relevant studies on the use of the available MALDI-TOF MS instruments, the implementation of innovative sample processing methods, or the implementation of improved databases are discussed. Insight about the methodology required for reliable identification of non-tuberculous mycobacteria and its implementation in the microbiology laboratory routine is provided. Microbiology laboratories where MALDI-TOF MS is available can benefit from its capacity to identify most clinically interesting non-tuberculous mycobacteria in a rapid, reliable, and inexpensive manner.